
Austin Murata
Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )
| Most Active Art Unit | 1712 |
| Art Unit(s) | 1792, 1712 |
| Total Applications | 876 |
| Issued Applications | 484 |
| Pending Applications | 86 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5648366
[patent_doc_number] => 20060134098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Immunoglobulin variable region cassette exchange'
[patent_app_type] => utility
[patent_app_number] => 11/282107
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19006
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134098.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282107
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282107 | Immunoglobulin variable region cassette exchange | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5614395
[patent_doc_number] => 20060116323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Tumor-inhibiting protein and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/273593
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6701
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273593
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273593 | Tumor-inhibiting protein and the use thereof | Nov 13, 2005 | Abandoned |
Array
(
[id] => 7689533
[patent_doc_number] => 20070105165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers'
[patent_app_type] => utility
[patent_app_number] => 11/267948
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12587
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267948
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267948 | Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers | Nov 3, 2005 | Abandoned |
Array
(
[id] => 5590464
[patent_doc_number] => 20060039915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'P-cadherin as a target for anti-cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/264046
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34258
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11264046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/264046 | P-cadherin as a target for anti-cancer therapy | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5813150
[patent_doc_number] => 20060083745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids'
[patent_app_type] => utility
[patent_app_number] => 11/254137
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 70491
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083745.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254137
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254137 | Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids | Oct 18, 2005 | Issued |
Array
(
[id] => 452790
[patent_doc_number] => 07247476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-24
[patent_title] => 'Individualized anti-cancer antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/241721
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6692
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/247/07247476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11241721
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/241721 | Individualized anti-cancer antibodies | Sep 29, 2005 | Issued |
Array
(
[id] => 5720370
[patent_doc_number] => 20060073144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Individualized anti-cancer antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/240787
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6615
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240787
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240787 | Individualized anti-cancer antibodies | Sep 29, 2005 | Abandoned |
Array
(
[id] => 5637480
[patent_doc_number] => 20060068453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation'
[patent_app_type] => utility
[patent_app_number] => 11/234308
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25510
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20060068453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234308
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234308 | Survivin, a protein that inhibits cellular apoptosis, and its modulation | Sep 25, 2005 | Abandoned |
Array
(
[id] => 5638051
[patent_doc_number] => 20060069025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation'
[patent_app_type] => utility
[patent_app_number] => 11/234225
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 25517
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234225 | Survivin, a protein that inhibits cellular apoptosis, and its modulation | Sep 25, 2005 | Abandoned |
Array
(
[id] => 7247282
[patent_doc_number] => 20050272092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Novel gene having reverse transcriptas motif'
[patent_app_type] => utility
[patent_app_number] => 11/199124
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7360
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199124 | Novel gene having reverse transcriptas motif | Aug 8, 2005 | Abandoned |
Array
(
[id] => 5747464
[patent_doc_number] => 20060110395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Use of CRKD as a breast cancer marker and cancer therapy target'
[patent_app_type] => utility
[patent_app_number] => 11/191457
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31699
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191457
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191457 | Use of CRKD as a breast cancer marker and cancer therapy target | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5045604
[patent_doc_number] => 20070264277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Compositions and Methods of Use for Mgd-Csf in Disease Treatment'
[patent_app_type] => utility
[patent_app_number] => 11/632319
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 53188
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632319 | Compositions and Methods of Use for Mgd-Csf in Disease Treatment | Jul 20, 2005 | Abandoned |
Array
(
[id] => 5630988
[patent_doc_number] => 20060147456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Induction of apoptosis in toll-like receptor expressing tumor cells'
[patent_app_type] => utility
[patent_app_number] => 11/184191
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12876
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184191
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184191 | Induction of apoptosis in toll-like receptor expressing tumor cells | Jul 18, 2005 | Abandoned |
Array
(
[id] => 6930779
[patent_doc_number] => 20050281813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins'
[patent_app_type] => utility
[patent_app_number] => 11/185567
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24969
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281813.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185567 | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins | Jul 18, 2005 | Abandoned |
Array
(
[id] => 7045560
[patent_doc_number] => 20050250155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Multiple marker characterization of single cells'
[patent_app_type] => utility
[patent_app_number] => 11/182897
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12036
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250155.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182897 | Multiple marker characterization of single cells | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5766764
[patent_doc_number] => 20060018898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Antibody variants'
[patent_app_type] => utility
[patent_app_number] => 11/180631
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9174
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11180631
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/180631 | Antibody variants | Jul 13, 2005 | Issued |
Array
(
[id] => 5726891
[patent_doc_number] => 20060057651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/171567
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 24087
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057651.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171567 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof | Jun 29, 2005 | Abandoned |
Array
(
[id] => 5865020
[patent_doc_number] => 20060099150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Compositions and methods for the transport of biologically active agents across cellular barriers'
[patent_app_type] => utility
[patent_app_number] => 11/169140
[patent_app_country] => US
[patent_app_date] => 2005-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 91064
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099150.pdf
[firstpage_image] =>[orig_patent_app_number] => 11169140
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/169140 | Compositions and methods for the transport of biologically active agents across cellular barriers | Jun 26, 2005 | Abandoned |
Array
(
[id] => 202977
[patent_doc_number] => 07632924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Antigen-binding polypeptides and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/155909
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 15
[patent_no_of_words] => 85936
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11155909
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/155909 | Antigen-binding polypeptides and their uses | Jun 16, 2005 | Issued |
Array
(
[id] => 7232885
[patent_doc_number] => 20050256049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Chimeric toxins for targeted therapy'
[patent_app_type] => utility
[patent_app_number] => 11/147360
[patent_app_country] => US
[patent_app_date] => 2005-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4724
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147360
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147360 | Chimeric toxins for targeted therapy | Jun 7, 2005 | Abandoned |